Cargando…

Influenza A Virus Pre-Infection Exacerbates Pseudomonas aeruginosa-Mediated Lung Damage Through Increased MMP-9 Expression, Decreased Elafin Production and Tissue Resilience

Individuals with impaired immune responses, such as ventilated and cystic fibrosis patients are often infected with Pseudomonas aeruginosa (P.a) bacteria, and a co-infection with the Influenza virus (IAV) is often present. It has been known for many years that infection with IAV predisposes the host...

Descripción completa

Detalles Bibliográficos
Autores principales: Villeret, Berengère, Solhonne, Brigitte, Straube, Marjolène, Lemaire, Flora, Cazes, Aurélie, Garcia-Verdugo, Ignacio, Sallenave, Jean-Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031978/
https://www.ncbi.nlm.nih.gov/pubmed/32117268
http://dx.doi.org/10.3389/fimmu.2020.00117
_version_ 1783499482744225792
author Villeret, Berengère
Solhonne, Brigitte
Straube, Marjolène
Lemaire, Flora
Cazes, Aurélie
Garcia-Verdugo, Ignacio
Sallenave, Jean-Michel
author_facet Villeret, Berengère
Solhonne, Brigitte
Straube, Marjolène
Lemaire, Flora
Cazes, Aurélie
Garcia-Verdugo, Ignacio
Sallenave, Jean-Michel
author_sort Villeret, Berengère
collection PubMed
description Individuals with impaired immune responses, such as ventilated and cystic fibrosis patients are often infected with Pseudomonas aeruginosa (P.a) bacteria, and a co-infection with the Influenza virus (IAV) is often present. It has been known for many years that infection with IAV predisposes the host to secondary bacterial infections (such as Streptococcus pneumoniae or Staphylococcus aureus), and there is an abundance of mechanistic studies, including those studying the role of desensitization of TLR signaling, type I IFN- mediated impairment of neutrophil chemokines and antimicrobial production, attenuation of IL1β production etc., showing this. However, little is known about the mechanistic events underlying the potential deleterious synergy between Influenza and P.a co-infections. We demonstrate here in vitro in epithelial cells and in vivo in three independent models (two involving mice given IAV +/– P.a, and one involving mice given IAV +/– IL-1β) that IAV promotes secondary P.a-mediated lung disease or augmented IL-1β-mediated inflammation. We show that IAV-P.a-mediated deleterious responses includes increased matrix metalloprotease (MMP) activity, and MMP-9 in particular, and that the use of the MMP inhibitor improves lung resilience. Furthermore, we show that IAV post-transcriptionally inhibits the antimicrobial/anti-protease molecule elafin/trappin-2, which we have shown previously to be anti-inflammatory and to protect the host against maladaptive neutrophilic inflammation in P.a infections. Our work highlights the capacity of IAV to promote further P.a-mediated lung damage, not necessarily through its interference with host resistance to the bacterium, but by down-regulating tissue resilience to lung inflammation instead. Our study therefore suggests that restoring tissue resilience in clinical settings where IAV/P.a co-exists could prove a fruitful strategy.
format Online
Article
Text
id pubmed-7031978
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-70319782020-02-28 Influenza A Virus Pre-Infection Exacerbates Pseudomonas aeruginosa-Mediated Lung Damage Through Increased MMP-9 Expression, Decreased Elafin Production and Tissue Resilience Villeret, Berengère Solhonne, Brigitte Straube, Marjolène Lemaire, Flora Cazes, Aurélie Garcia-Verdugo, Ignacio Sallenave, Jean-Michel Front Immunol Immunology Individuals with impaired immune responses, such as ventilated and cystic fibrosis patients are often infected with Pseudomonas aeruginosa (P.a) bacteria, and a co-infection with the Influenza virus (IAV) is often present. It has been known for many years that infection with IAV predisposes the host to secondary bacterial infections (such as Streptococcus pneumoniae or Staphylococcus aureus), and there is an abundance of mechanistic studies, including those studying the role of desensitization of TLR signaling, type I IFN- mediated impairment of neutrophil chemokines and antimicrobial production, attenuation of IL1β production etc., showing this. However, little is known about the mechanistic events underlying the potential deleterious synergy between Influenza and P.a co-infections. We demonstrate here in vitro in epithelial cells and in vivo in three independent models (two involving mice given IAV +/– P.a, and one involving mice given IAV +/– IL-1β) that IAV promotes secondary P.a-mediated lung disease or augmented IL-1β-mediated inflammation. We show that IAV-P.a-mediated deleterious responses includes increased matrix metalloprotease (MMP) activity, and MMP-9 in particular, and that the use of the MMP inhibitor improves lung resilience. Furthermore, we show that IAV post-transcriptionally inhibits the antimicrobial/anti-protease molecule elafin/trappin-2, which we have shown previously to be anti-inflammatory and to protect the host against maladaptive neutrophilic inflammation in P.a infections. Our work highlights the capacity of IAV to promote further P.a-mediated lung damage, not necessarily through its interference with host resistance to the bacterium, but by down-regulating tissue resilience to lung inflammation instead. Our study therefore suggests that restoring tissue resilience in clinical settings where IAV/P.a co-exists could prove a fruitful strategy. Frontiers Media S.A. 2020-02-13 /pmc/articles/PMC7031978/ /pubmed/32117268 http://dx.doi.org/10.3389/fimmu.2020.00117 Text en Copyright © 2020 Villeret, Solhonne, Straube, Lemaire, Cazes, Garcia-Verdugo and Sallenave. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Villeret, Berengère
Solhonne, Brigitte
Straube, Marjolène
Lemaire, Flora
Cazes, Aurélie
Garcia-Verdugo, Ignacio
Sallenave, Jean-Michel
Influenza A Virus Pre-Infection Exacerbates Pseudomonas aeruginosa-Mediated Lung Damage Through Increased MMP-9 Expression, Decreased Elafin Production and Tissue Resilience
title Influenza A Virus Pre-Infection Exacerbates Pseudomonas aeruginosa-Mediated Lung Damage Through Increased MMP-9 Expression, Decreased Elafin Production and Tissue Resilience
title_full Influenza A Virus Pre-Infection Exacerbates Pseudomonas aeruginosa-Mediated Lung Damage Through Increased MMP-9 Expression, Decreased Elafin Production and Tissue Resilience
title_fullStr Influenza A Virus Pre-Infection Exacerbates Pseudomonas aeruginosa-Mediated Lung Damage Through Increased MMP-9 Expression, Decreased Elafin Production and Tissue Resilience
title_full_unstemmed Influenza A Virus Pre-Infection Exacerbates Pseudomonas aeruginosa-Mediated Lung Damage Through Increased MMP-9 Expression, Decreased Elafin Production and Tissue Resilience
title_short Influenza A Virus Pre-Infection Exacerbates Pseudomonas aeruginosa-Mediated Lung Damage Through Increased MMP-9 Expression, Decreased Elafin Production and Tissue Resilience
title_sort influenza a virus pre-infection exacerbates pseudomonas aeruginosa-mediated lung damage through increased mmp-9 expression, decreased elafin production and tissue resilience
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031978/
https://www.ncbi.nlm.nih.gov/pubmed/32117268
http://dx.doi.org/10.3389/fimmu.2020.00117
work_keys_str_mv AT villeretberengere influenzaaviruspreinfectionexacerbatespseudomonasaeruginosamediatedlungdamagethroughincreasedmmp9expressiondecreasedelafinproductionandtissueresilience
AT solhonnebrigitte influenzaaviruspreinfectionexacerbatespseudomonasaeruginosamediatedlungdamagethroughincreasedmmp9expressiondecreasedelafinproductionandtissueresilience
AT straubemarjolene influenzaaviruspreinfectionexacerbatespseudomonasaeruginosamediatedlungdamagethroughincreasedmmp9expressiondecreasedelafinproductionandtissueresilience
AT lemaireflora influenzaaviruspreinfectionexacerbatespseudomonasaeruginosamediatedlungdamagethroughincreasedmmp9expressiondecreasedelafinproductionandtissueresilience
AT cazesaurelie influenzaaviruspreinfectionexacerbatespseudomonasaeruginosamediatedlungdamagethroughincreasedmmp9expressiondecreasedelafinproductionandtissueresilience
AT garciaverdugoignacio influenzaaviruspreinfectionexacerbatespseudomonasaeruginosamediatedlungdamagethroughincreasedmmp9expressiondecreasedelafinproductionandtissueresilience
AT sallenavejeanmichel influenzaaviruspreinfectionexacerbatespseudomonasaeruginosamediatedlungdamagethroughincreasedmmp9expressiondecreasedelafinproductionandtissueresilience